Brain tumor tissue bank could unlock new drug targets

NCT ID NCT04852354

Recruiting now Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects leftover brain and spinal cord tumor tissue from 500 patients during surgery or autopsy. Researchers will use the tissue to create cell lines and models to test how different drugs work. The goal is to better understand these tumors and find new ways to treat them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to better treatments and new therapy targets for central nervous system tumors.
What could go wrong: This is an early-stage tissue collection study, not a treatment trial. Results may not directly benefit participants or lead to immediate therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central nervous system cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL NERVOUS SYSTEM TUMOR

Contacts and locations

Locations

Weill Cornell Medicine
RECRUITING

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.